
Questions? We’ve Got You Covered
What is BPC-157 Joint Cream?
BPC-157 Joint Cream is a topical joint care product with BPC-157 peptide as the core active ingredient. BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids, the sequence of which is derived from protective proteins found in human gastric secretions, with recognised tissue repair and anti-inflammatory potential. By combining BPC-157 with a gentle, nourishing cream base, this joint cream is designed to be applied topically to the joints and surrounding soft tissues to assist in the relief of joint discomfort and support tissue repair.
BPC-157 How does Joint Cream work?
Its core action is realised through the multiple mechanisms of BPC-157, which works in conjunction with the characteristics of the topical dosage form.
- Anti-inflammatory and soothing: BPC-157 can inhibit the release of local inflammatory factors in the joints, reduce inflammation and relieve redness, swelling and pain caused by inflammation.
- Promote Repair: It can accelerate the migration of fibroblasts and tissue regeneration, and help the repair process of damaged tendons, ligaments and articular cartilage, especially for the recovery after sports injury.
- Enhancement of tolerance: By activating the FAK-paxillin signalling pathway, it improves the survival rate of joint cells under oxidative stress and enhances the resistance of joint tissues to damage.
- Local penetration: the moisturising and penetrating ingredients in the cream base help BPC-157 to penetrate the skin surface and reach the periarticular lesions.
How does this joint cream differ from ordinary joint care products?
Compared to conventional joint creams (such as analgesic products containing solely capsaicin or methyl salicylate, or nourishing creams containing only moisturising ingredients), its core advantages lie in:
- Uniqueness of active ingredients: Centred on research-grade repair peptides rather than relying on irritant analgesics, its action focuses more on ‘addressing the root cause’ rather than merely ‘temporary pain relief’;
- Mechanism Synergy: Simultaneously addresses ‘anti-inflammatory, restorative, and cellular protective’ functions, rather than offering solely soothing or moisturising effects;
Ingredient Safety: BPC-157 derives from naturally occurring human protein fragments, exhibiting superior biocompatibility when applied topically and minimising the risk of chemical irritation reactions.
Who is BPC-157 Joint Cream suitable for?
Suitable for individuals requiring daily joint care or experiencing specific joint discomfort, including:
- Middle-aged and elderly individuals: Daily aches and stiffness arising from degenerative joint changes (such as knee or lumbar joint discomfort);
- Sports enthusiasts: For supplementary care of post-exercise joint strain and minor tendon injuries (e.g., recovery from tennis elbow or ankle sprains);
- Office workers: For stiffness in the cervical spine and shoulder joints caused by prolonged desk work, or joint discomfort resulting from
- frequent wrist use;
Individuals in the post-operative recovery phase: Under medical guidance, for supplementary care supporting local tissue repair following joint surgery.
How long does it take to see results?
Results may vary depending on individual differences, the cause of discomfort, and its severity:
- Short-term (3-7 days): Most users experience significant relief from joint soreness and stiffness, with particularly noticeable effects on acute sports injuries.
- Mid-term (2-4 weeks): Joint mobility improves, with reduced morning stiffness and soreness when climbing stairs. Damaged tissues enter the repair phase.
- Long-term (8+ weeks): Consistent long-term use enhances joint stability and reduces recurrence of discomfort, making it particularly suitable for daily maintenance of degenerative joint conditions in middle-aged and elderly individuals.
Are there any safety risks associated with long-term use?
Current research and clinical observations indicate that long-term topical application of BPC-157 joint cream at recommended doses demonstrates high safety:
- No dependency: The formulation contains no addictive substances; discontinuation does not induce withdrawal reactions or symptom rebound.
- No toxic accumulation: BPC-157 is readily metabolised into amino acids within the body, imposing no burden on liver or kidney function. Long-term use requires no monitoring of hepatic or renal parameters.
- Precautions: It is advisable to pause use for 1–2 weeks after every two cycles (16 weeks) to allow the skin and joint tissues to rest. Individuals with specific health conditions should consult their physician to establish a tailored usage plan.
























Specifications:

